Dr Bridget Bax completed her PhD the Royal Postgraduate Medical School, University of London. She is currently a Reader in Rare Diseases at City St George’s University of London. She is internationally recognised for her research on mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), including pioneering enzyme replacement strategies using red blood cells. Dr. Bax has published extensively and leads translational research aimed at improving diagnosis and treatment for patients with ultra-rare conditions.